Insider trades
Mike Mensinger, Chief Officer of Beta Bionics BBNX, has filed 1 purchase and 11 sales on the open market. Over the past 12 months that comes to a net sale of $396.7K. The latest trade was on 06/02.
Mike Mensinger
Chief Product Officer
- Company
- Beta Bionics BBNX
- First filing
- 25/01/31
- Trades
- 25 trades
- Buys / sales
- 1 / 11
- 12-month net buying
- −$396.7K
- Last trade
- 06/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Beta BionicsBBNX | Open-market sale | 06/02 | 06/03 | 4,378 sh | $12.61 | $55,206.58 | −2.3% |
Beta BionicsBBNX | Open-market sale | 03/02 | 03/03 | 1,064 sh | $12.36 | $13,151.04 | −0.6% |
Beta BionicsBBNX | Open-market sale10b5-1 plan | 01/06 | 01/07 | 2,200 sh | $30.10 | $66,220 | −2.7% |
BBNX | Open-market sale10b5-1 plan | 01/02 | 01/05 | 7,800 sh2 trades | $29.61avg. | $230,952 | −8.6% |
Beta BionicsBBNX | Open-market sale | 25/12/02 | 25/12/04 | 1,063 sh | $29.34 | $31,188.42 | −1.2% |
Beta BionicsBBNX | Open-market sale | 25/09/02 | 25/09/04 | 1,089 sh | $18.86 | $20,538.54 | −1.2% |
BBNX | Open-market sale | 25/06/02 | 25/06/04 | 1,115 sh3 trades | $17.89avg. | $19,949.07 | −1.2% |
Beta BionicsBBNX | Open-market buy | 25/01/31 | 25/02/03 | 33,350 sh | $17.00 | $566,950 | +129.9% |
Beta BionicsBBNX | Open-market sale | 25/01/31 | 25/02/03 | 13 sh | $17.00 | $221 | −0.1% |